Clinical studies show 50-60% response rate for TMS therapy in treating major depressive disorder, with 30-35% of patients achieving full remission.
TMS therapy has been extensively studied for treatment-resistant depression. In randomized controlled trials and real-world clinical settings, the majority of patients experience meaningful symptom reduction. Those who have failed multiple antidepressant medications often respond particularly well to TMS.
The NeuroStar Outcomes study, one of the largest real-world evidence studies in TMS, demonstrated that patients treated with TMS showed significant improvement in depression severity scores. Benefits typically begin appearing within 2-3 weeks of starting treatment.
Key Depression Treatment Options
Explore TMS and other evidence-based treatments for major depressive disorder.
Explore Depression Treatment